The Impact of Multifaceted Osteoporosis Group Education on Patients’ Decision-Making regarding Treatment Options and Lifestyle Changes
Table 1
Patients’ demographic and osteoporosis related characteristics at the end of study period.
Patient ID: F, N/class ID
Age (SD)
Gender
Occupation
Lives alone
Educational background
Years with osteoporosis before GE
Calcium tablets ()
Osteoporosis medication
F1/c
88
Female
Retired
+
Primary school
16
Zoledronic acid
F2/c
61
Female
Incapacity benefit
−
Short extensive education
5
0
Denosumab
F3/d
46
Male
Job training
−
Vocational school
1
2
F4/d
71
Male
Retired
−
Primary school
0
2
F5/d
57
Male
Working
+
Vocational school
0
2
Alendronate
F6/e
61
Female
Incapacity benefit
+
Vocational school
0
2
Alendronate
F7/e
62
Female
Incapacity benefit
+
Vocational school
11
2
Zoledronic acid
F8/e
61
Female
Working
−
Bachelor’s degree
8
Alendronate
F-Mean
63.4 (12.1)
N1/a
57
Female
Retired
−
Vocational school
0
2
N2/a
53
Female
Working
−
Bachelor’s degree
1
Alendronate
N3/a
83
Female
Retired
+
Vocational school
5
2
None
N4/a
57
Female
Working
+
Bachelor’s degree
5
Alendronate
N5/a
69
Female
Retired
+
Bachelor’s degree
2
None
N6/a
56
Female
Working
−
Bachelor’s degree
1
2
Denosumab
N7b
63
Female
Retired
−
Bachelor’s degree
0
Alendronate
N8/b
56
Female
Working
−
Bachelor’s degree
0
Alendronate
N9/b
69
Female
Retired
−
Short extensive education
3
Alendronate
N-Mean
62.5 (9.6)
F: one or more vertebral fractures; N: no vertebral fracture; SD: standard deviation. medication, amount of D-vitamin, number of calcium tablets, sort of calcium tablet or time of day for taking calcium tablet type or amount of calcium or in the study period.
